[Therapy of extrapyramidal-motor symptoms. Drug treatment].
D000470:Alkaloids / Q000627:therapeutic use; D001532:Atropa belladonna / Q000627:therapeutic use; D004295:Dihydroxyphenylalanine / Q000627:therapeutic use; D005116:Extrapyramidal Tracts; D006801:Humans; D008996:Monoamine Oxidase Inhibitors / Q000627:therapeutic use; D009069:Movement Disorders / Q000188:drug therapy*; D010276:Parasympatholytics / Q000008:administration & dosage / Q000009:adverse effects / Q000145:classification / Q000627:therapeutic use; D010300:Parkinson Disease / Q000188:drug therapy; D008517:Phytotherapy; D010946:Plants, Medicinal; D010947:Plants, Toxic; D013035:Spasm / Q000188:drug therapy; D013064:Speech Disorders / Q000188:drug therapy; D014202:Tremor / Q000188:drug therapy
D000470:Alkaloids; D008996:Monoamine Oxidase Inhibitors; D010276:Parasympatholytics; D004295:Dihydroxyphenylalanine
Die Therapie der extrapyramidal-motorischen Symptome. Die medikamentöse Behandlung.